Cargando…
449. Performance of the Brighton Case Definition for Multisystem Inflammatory Syndrome in Children (MIS-C) Among a Large Single Center Cohort
BACKGROUND: Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare, life-threatening, hyperinflammatory condition presumed to follow SARS-CoV-2 infection. Whether MIS-C can also follow SARS-CoV-2 vaccination is not clear, making MIS-C an adverse event of special interest following immunizat...
Autores principales: | Nguyen, Jessica, Osuna, Isabella, Muscal, Eyal, Sexson, Kristen, DeGuzman, Marietta, Munoz, Flor M, Vogel, Tiphanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644073/ http://dx.doi.org/10.1093/ofid/ofab466.648 |
Ejemplares similares
-
Outcomes After SARS-CoV-2 Vaccination Among Children With a History of Multisystem Inflammatory Syndrome
por: Wisniewski, Matthew, et al.
Publicado: (2022) -
1075. The MET Project: Distinguishing Multisystem Inflammatory Syndrome in Children from Typhus Using Artificial Intelligence
por: Chun, Angela, et al.
Publicado: (2022) -
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
por: Vogel, Tiphanie P., et al.
Publicado: (2021) -
Comparison of Laboratory and Hemodynamic Time Series Data Across Original, Alpha, and Delta Variants in Patients With Multisystem Inflammatory Syndrome in Children
por: Jain, Parag N., et al.
Publicado: (2022) -
Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management
por: Molloy, Eleanor J., et al.
Publicado: (2022)